在心力衰竭中左束支部区域节奏:系统性审查和分析与回归
Mahmoud El Iskandarani1, Reshma Golamari2, Islam Shatla3
1Department Internal Medicine, Eastern Connecticut Health Network, Manchester, Connecticut, USA.
Journal of cardiovascular electrophysiology
|May 30, 2024
概括
左捆支部区域节奏 (LBBAP) 是心力衰竭患者的双心室节奏的可行和有效替代方案. 与双心室节奏相比,LBBAP改善了电同步,心脏功能,并减少了住院和死亡率.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏衰竭管理的管理
背景情况:
- 心脏再同步疗法 (CRT) 是为心力衰竭 (HF) 患者建立的,患者的喷射分数减少和左捆分支块 (LBBB).
- 左捆分支区域节奏 (LBBAP) 正成为CRT的一个潜在的更生理的方法.
- 这项研究综合了关于LBBAP可行性,有效性和安全性的证据.
研究的目的:
- 总结关于左捆分支区块区域节奏 (LBBAP) 的现有证据.
- 评估LBBAP作为CRT策略的可行性,有效性和安全性.
- 为了比较LBBAP结果与传统的双心脏节奏 (BVP).
主要方法:
- 在PubMed,EMBASE和Cochrane数据库中进行了系统的文献搜索.
- 使用元分析和元回归来综合从已识别的研究中获得的数据.
- 包括的研究包括17项观察性研究和1项随机对照试验.
主要成果:
- 在3906名心力衰竭患者中,LBBAP表现出高的手术成功率 (90.4%).
- 与基线相比,LBBAP显著减少了QRS持续时间,改善了左心室喷射率 (LVEF),并降低了NYHA类.
- LBBAP显示QRS缩小优异,LVEF改善与双心脏节奏 (BVP) 相比,HF住院和全因死亡率明显降低.
结论:
- 左捆支部区域节奏 (LBBAP) 是一种安全有效的替代方案,用于CRT的双心脏节奏 (BVP).
- LBBAP显著增强了心室电同步,从而导致更好的心声回声和临床结果.
- LBBAP提供了一种有前途的方法来改善LBBB患者心力衰竭的结果.
相关概念视频
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K


